PhI Efficacy of Single&Multiple Doses of Oral AdminHS-10382 (TERN-701) in Ps w/Chronic Myeloid LeukRichard Van EttenOPEN TO ACCRUALGet More Information
Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation (ADAPT) Stefan Octavian CiureaOPEN TO ACCRUALGet More Information
PhI Ven/Aza Comb.w/ Ziftomenib or Cytarabine/Daunorubicin Comb.w/ Ziftomenib for Tx of Pts w/ AMLDeepa JeyakumarOPEN TO ACCRUALGet More Information
PhIII Odronextamab Comb w/CHOP vs Rituximab Comb w/CHOP in Prev Untrx Pts w/Diffuse Large Bcell LympElizabeth A BremOPEN TO ACCRUALGet More Information
PhII/III NABPLAGEMvsNabPaclitaxel/Gemcitabine BRCA1/2PALB2MutantMetaPancreaticDuctalAdenoCaJennifer Brooke ValerinOPEN TO ACCRUALGet More Information
PhI BI 1810631 as Monotherapy in Pts w/ Adv or Metastatic Solid Tumors w/ HER2 AberrationsMisako NagasakaOPEN TO ACCRUALGet More Information
Long-Term Follow-Up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)Manisha KorbOPEN TO ACCRUALGet More Information
Study of Oral FT-4202, a Pyruvate Kinase Agonist in Patients with Sickle Cell Disease (Hibiscus)Zahra PakbazOPEN TO ACCRUALGet More Information
Observational Study of Pts w/ R/R DLBCL 2nd or 3rd-Line Therapy & Not Receiving ASCT Elizabeth A BremOPEN TO ACCRUALGet More Information
Safety and efficacy of AB-1003 in subjects (ages 18-65) with LGMD2I/R9 impacting FKRPTahseen MozaffarOPEN TO ACCRUALGet More Information
Ph1 MuSK-CAART for subjects with Anti-MuSK-antibody-positive MGAli HabibOPEN TO ACCRUALGet More Information
A Phase Ia/Ib Study of LY3537982 in Patients with KRAS G12C-Mutant Advanced Solid Tumors Misako NagasakaOPEN TO ACCRUALGet More Information
R5459-RT-1944: Study for Desensitization of Chronic Kidney Disease in Adult Patients in Need of a KiRobert Redfield IIIOPEN TO ACCRUALGet More Information
PhI/IINivolumab+-Ipilimumabw/MultiFractionStereotacticRadiosurRecurHighGradeRadiationRelapsedMeningiAaron SimonOPEN TO ACCRUALGet More Information